• Filter By:

Use of AI Plus One Radiologist Noninferior for Detecting Breast Cancer
MONDAY, Sept. 18, 2023 -- Double reading of screening mammograms by one radiologist plus artificial intelligence (AI) is noninferior to standard-of-care double reading by two radiologists, according to a study published online Sept. 8 in The Lancet...
Source: Drugs.com - Pharma News - September 18, 2023 Category: Pharmaceuticals Source Type: news

Risk for Intracerebral Hemorrhage May Be Transmissible Via Blood Transfusion
MONDAY, Sept. 18, 2023 -- The risk for spontaneous intracerebral hemorrhage (ICH) is increased for patients who receive red blood cell transfusions from donors who later develop multiple spontaneous ICHs, according to a study published in the Sept....
Source: Drugs.com - Pharma News - September 18, 2023 Category: Pharmaceuticals Source Type: news

Cases of Pediatric Therapeutic Errors Related to ADHD Meds on the Rise
MONDAY, Sept. 18, 2023 -- From 2000 to 2021, there was an almost 300 percent increase in the annual frequency of cases of pediatric out-of-hospital therapeutic errors related to attention-deficit/hyperactivity disorder (ADHD) medications, according...
Source: Drugs.com - Pharma News - September 18, 2023 Category: Pharmaceuticals Source Type: news

Air Pollution Exposure Tied to Smaller Babies at Birth
MONDAY, Sept. 18, 2023 -- Women exposed to air pollution deliver babies with lower birth weights; however, women living in greener areas give birth to larger babies, which may help counteract the negative effects of air pollution on birth weight,...
Source: Drugs.com - Pharma News - September 18, 2023 Category: Pharmaceuticals Source Type: news

Both Maternal, Paternal Substance Use Disorder Tied to Offspring Intellectual Disability
MONDAY, Sept. 18, 2023 -- Both paternal and maternal substance use disorder (SUD) are associated with an increased risk for intellectual disability in offspring, according to a study published in the September issue of eClinicalMedicine. Lotfi...
Source: Drugs.com - Pharma News - September 18, 2023 Category: Pharmaceuticals Source Type: news

Ventilatory Burden Can Assess Severity of Obstructive Sleep Apnea
MONDAY, Sept. 18, 2023 -- Automated ventilatory burden, which represents the proportion of overnight breaths with<50 percent normalized amplitude, can measure the severity of obstructive sleep apnea (OSA), according to a study published online...
Source: Drugs.com - Pharma News - September 18, 2023 Category: Pharmaceuticals Source Type: news

AAP Issues Low-Carb Diet Recommendations for Pediatric Diabetes
MONDAY, Sept. 18, 2023 -- In a clinical report issued by the American Academy of Pediatrics and published online Sept. 18 in Pediatrics, recommendations are presented for use of low-carbohydrate diets in children with type 1 diabetes, prediabetes,...
Source: Drugs.com - Pharma News - September 18, 2023 Category: Pharmaceuticals Source Type: news

AI Tool May Aid Remote Assessment of Parkinson Symptom Severity
MONDAY, Sept. 18, 2023 -- An artificial intelligence tool can help remotely assess the severity of Parkinson disease symptoms, according to a study published online Aug. 23 in npj Digital Medicine. Saiful Islam, from the University of Rochester in...
Source: Drugs.com - Pharma News - September 18, 2023 Category: Pharmaceuticals Source Type: news

Advanced Young-Onset Adenoma Increases Colorectal Cancer Risk
MONDAY, Sept. 18, 2023 -- Advanced young-onset adenoma (YOA) increases the risk for new colorectal cancer (CRC) eightfold, according to a study published online in the September issue of the American Journal of Gastroenterology. Yas Casey, M.D.,...
Source: Drugs.com - Pharma News - September 18, 2023 Category: Pharmaceuticals Source Type: news

Revaccination Suggested for Hep B Vaccine Nonresponders After Hep C Cure
MONDAY, Sept. 18, 2023 -- Patients with chronic hepatitis C virus (HCV) who do not respond to hepatitis B virus (HBV) vaccine should undergo revaccination after HCV treatment and eradication, according to a study published online July 31 in The...
Source: Drugs.com - Pharma News - September 18, 2023 Category: Pharmaceuticals Source Type: news

To Really Impact Healthcare Costs Look Beyond Drug Prices
At a time when the opportunities for discovering and developing new medicines is the greatest in our history, we will be doing less. What we really should be doing is investing more in order to generate new medicines thus reducing downstream healthcare costs.
Source: Forbes.com Healthcare News - September 18, 2023 Category: Pharmaceuticals Authors: John LaMattina, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma standard Source Type: news

The Joint Commission Launches Certification In Sustainability For U.S. Hospitals
The Joint Commission, accreditor of U.S. healthcare facilities, is rolling out a voluntary certification in sustainability as hospitals look to combat climate change.
Source: Forbes.com Healthcare News - September 18, 2023 Category: Pharmaceuticals Authors: Bruce Japsen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Enterprise Tech /enterprise-tech business pharma standard Source Type: news

Vividion Therapeutics starts Phase I clinical trial in advanced solid tumors with KEAP1 activator
Vividion Therapeutics, Inc. (Vividion), announced today that it has initiated dosing of patients in a Phase I oncology clinical trial of its investigational oral Kelch-like ECH Associated Protein 1 (KEAP1) activator, VVD-130037. Vividion is a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision therapeutics for devastating cancers and immune disorders, and a wholly owned and independently operated subsidiary of Bayer AG.
Source: World Pharma News - September 18, 2023 Category: Pharmaceuticals Tags: Featured Bayer Business and Industry Source Type: news

Ozempic maker Novo Nordisk isn ' t just Europe ' s second-most valuable company. It is also singlehandedly boosting Denmark ' s economy
None It's also boosting Denmark's economy all on its own. • None Denmark's GDP grew 1.7% in 1H 2023. It would've contracted by 0.3% if not for the pharma sector. Weight loss drug Ozempic is such a blockbuster hit that its maker, Novo Nordisk, has become one of the most high-profile companies in…#denmark #weight #novonordisk #danishkroner #louisvuitton #ozempicandwegovy #elonmusk #amyschumer #danish #lasolsen
Source: Reuters: Health - September 18, 2023 Category: Consumer Health News Source Type: news

PAROXETINE (paroxetine hydrochloride) tablet, film coated Aurobindo Pharma Limited
Updated Date: Mon, 18 Sep 2023 00:00:00 EDT
Source: DailyMed Drug Label Updates - September 18, 2023 Category: Drugs & Pharmacology Source Type: alerts

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20